Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolateScan in Pituitary Tumors
NCT01689727Phase 2Completed
- Sponsor
- Endocyte
- Start
- Sep 2002
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etarfolatide in pituitary tumor, sponsored by Endocyte. Started Sep 2002; status: completed.
02
Drugs
etarfolatide
03
Conditions
pituitary tumor
Beyond the preview
Go deeper on NCT01689727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689727.